Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Rotavirus Vaccine Development
Candidate rotavirus vaccines derived from neonatal strains developed
October 23rd, 2005
Scientists have developed candidate rotavirus vaccines derived from neonatal strains in India. "The need for a rotavirus vaccine in India is based on the enormous burden associated with the 1100,000 deaths due to rotavirus diarrhea that occur annually among Indian children. Two rotavirus strains identified during nosocomial outbreaks of rotavirus infection in New Delhi and Bangalore, India, more than a decade ago are being developed as live oral vaccines," scientists in the United States and India report. "Infected newborns had no symptoms, shed virus for up to 2 weeks after infection, mounted a robust immune response, and demonstrated protection...
Source: Medical Letter on the CDC & FDA (2005-10-23)
|
